{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:26:25Z","timestamp":1787167585442,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Dermatol Online J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/idoj.idoj_62_16","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T10:57:41Z","timestamp":1649933861000},"page":"224","source":"Crossref","is-referenced-by-count":18,"title":["Bimatoprost in dermatology"],"prefix":"10.4103","volume":"9","author":[{"given":"AbhijeetK","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"UdayK","family":"Udayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PK","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AmarK","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. K. P","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5178.231725-1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.bjp.0707434","article-title":"Prostamides (prostaglandin- ethanolamides) and their pharmacology","author":"Woodward","year":"2008","journal-title":"Br J Pharmacol"},{"key":"key-10.4103\/2229-5178.231725-2","unstructured":"Smyth EM, Burke A, FitzGerald GA. Lipid-derived autacoids: Eicosanoids and platelet-activating factor. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gillman's the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2005. p. 653-70."},{"key":"key-10.4103\/2229-5178.231725-3","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1016\/S0039-6257(01)00224-7","article-title":"The pharmacology of bimatoprost (Lumigant)","author":"Woodward","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/2229-5178.231725-4","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0039-6257(02)00327-2","article-title":"Bimatoprost and travoprost: Areview of recent studies of two new glaucoma drugs","author":"Eisenberg","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/2229-5178.231725-5","doi-asserted-by":"crossref","unstructured":"Woodward DF, Carling RW, Cornell C.L, Fliri HG, Martos JL, Pettit SN, et al. The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. Pharmacol Ther 2008;120:71-80","DOI":"10.1016\/j.pharmthera.2008.08.001"},{"key":"key-10.4103\/2229-5178.231725-6","first-page":"S149\u201350","article-title":"Hypertrichosis of the eyelashes caused by bimatoprost","author":"Tosti","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.231725-7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0625.2007.00639.x","article-title":"Prostanoid receptors in anagen human hair follicles","author":"Colombe","year":"2008","journal-title":"Exp Dermatol"},{"key":"key-10.4103\/2229-5178.231725-8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM199908123410706","article-title":"The biology of hair follicles","author":"Paus","year":"1999","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2229-5178.231725-9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1529-8019.2008.00214.x","article-title":"Androgens and hair growth","author":"Randall","year":"2008","journal-title":"Dermatol Ther"},{"key":"key-10.4103\/2229-5178.231725-10","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1365-2133.2010.09685.x","article-title":"Characterization of an in vivo model for the study of eyelash biology and trichomegaly: Mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost","author":"Tauchi","year":"2010","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.231725-11","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/S0039-6257(02)00307-7","article-title":"Prostaglandin-induced hair growth","author":"Johnstone","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/2229-5178.231725-12","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archopht.118.5.718","article-title":"Eyelash formation secondary to latanoprost treatment in a patient with alopecia","author":"Mansberger","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2229-5178.231725-13","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archopht.123.11.1541","article-title":"Bimatoprost-Induced Periocular Skin Hyperpigmentation: Histopathological Study","author":"Kapur","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2229-5178.231725-14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaad.2011.06.005","article-title":"Eyelash growth in subjects treated with bimatoprost: Amulticenter, randomized, double-masked, vehicle-controlled, parallel-group study","author":"Smith","year":"2012","journal-title":"J AmAcad Dermatol"},{"key":"key-10.4103\/2229-5178.231725-15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaad.2008.08.029","article-title":"Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata","author":"Roseborough","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.231725-16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0974-7753.77511","article-title":"Bimatoprost in the treatment of eyelash universalis alopecia areata","author":"Vila","year":"2010","journal-title":"Int J Trichol","ISSN":"https:\/\/id.crossref.org\/issn\/0974-7753","issn-type":"print"},{"key":"key-10.4103\/2229-5178.231725-17","doi-asserted-by":"crossref","unstructured":"Morris CL, Stinnett SS, Woodward JA. The role of bimatoprost eyelash gel in chemotherapy-induced madarosis: An analysis of efficacy and safety. Int J Trichol 2011;3:84-91","DOI":"10.4103\/0974-7753.90809"},{"key":"key-10.4103\/2229-5178.231725-18","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1038\/jidsymp.2013.30","article-title":"Safety and efficacy of bimatoprost solution 0.03% topical application in patients with chemotherapy-induced eyelash loss","author":"Ahluwalia","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"key":"key-10.4103\/2229-5178.231725-19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/dsu.12199","article-title":"Treatment of eyebrow hypotrichosis using bimatoprost: Arandomized, double-blind, vehicle-controlled pilot study","author":"Beer","year":"2013","journal-title":"Dermatol Surg"},{"key":"key-10.4103\/2229-5178.231725-20","first-page":"11","article-title":"Safety and efficacy of bimatoprost for eyelash growth in postchemotherapy subjects","author":"Wirta","year":"2015","journal-title":"J Clin Aesthet Dermatol"},{"key":"key-10.4103\/2229-5178.231725-21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1096\/fj.12-218156","article-title":"The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias","author":"Khidhir","year":"2013","journal-title":"FASEB J"},{"key":"key-10.4103\/2229-5178.231725-22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000371416","article-title":"Bimatoprost versus mometasone furoate in the treatment of scalp alopecia areata: A Pilot Study","author":"Zaher","year":"2015","journal-title":"Dermatology"},{"key":"key-10.4103\/2229-5178.231725-23","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archopht.123.11.1541","article-title":"Bimatoprost-induced periocular skin hyperpigmentation: Histopathological study","author":"Kapur","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2229-5178.231725-24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1468-3083.2009.03346.x","article-title":"Skin pigmentation after NB-UVB and three analogues of prostaglandin F2\u03b1 in guinea pigs: Acomparative study","author":"Anbar","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/2229-5178.231725-25","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/jdv.13176","article-title":"Bimatoprost in periorbital vitiligo: A ray of hope or dilemma","author":"Jha","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/2229-5178.231725-26","first-page":"821\u20132","article-title":"Bimatoprost in vitiligo","author":"Jha","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/2229-5178.231725-27","first-page":"703\u201310","article-title":"Bimatoprost 0.03% Solution for the Treatment of Nonfacial Vitiligo","author":"Grimes","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/2229-5178.231725-28","unstructured":"Lumigan [Package Insert] Allergan Inc.; Irvine, CA: Sep, 2006. [Jul 27;2010]."},{"key":"key-10.4103\/2229-5178.231725-29","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/bjo.2007.128454","article-title":"For the Bimatoprost Study Group.Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucomaand ocular hypertension: Year 4","author":"Williams","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/2229-5178.231725-30","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archopht.120.10.1286","article-title":"For the Bimatoprost Study Groups 1 and 2.One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension","author":"Higginbotham","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2229-5178.231725-31","doi-asserted-by":"crossref","first-page":"162S","DOI":"10.1016\/S0039-6257(02)00292-8","article-title":"Mechanism and clinical significance of prostaglandin-induced iris pigmentation","author":"Stjernschantz","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/2229-5178.231725-32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2147\/OPTH.S55754","article-title":"Periorbital muscle atrophy associated with topical bimatoprost therapy","author":"Wang","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/2229-5178.231725-33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/01676830.2010.527028","article-title":"Periorbital fat atrophy \u2013 an unfamiliar side effect of prostaglandin analogues","author":"Jayaprakasam","year":"2010","journal-title":"Orbit"},{"key":"key-10.4103\/2229-5178.231725-34","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/1090820X12455659","article-title":"Topical bimatoprost 0.03% and iatrogenic eyelid and orbital lipodystrophy","author":"Sira","year":"2012","journal-title":"Aesthet Surg J"},{"key":"key-10.4103\/2229-5178.231725-35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/01.opx.0000141791.16683.4a","article-title":"Deepening of lid sulcus from topical bimatoprost therapy","author":"Peplinski","year":"2004","journal-title":"Optom Vis Sci"},{"key":"key-10.4103\/2229-5178.231725-36","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/jop.2011.0160","article-title":"In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadipocytes","author":"Choi","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.4103\/2229-5178.231725-37","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1524-4725.2010.01522.x","article-title":"Enhancing the growth of natural eyelashes: The mechanism of bimatoprost-induced eyelash growth","author":"Cohen","year":"2010","journal-title":"Dermatol Surg"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:24:12Z","timestamp":1787163852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.IDOJ_62_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"alternative-id":["231725"],"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_62_16","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}